Skip to content
CorpDev.Org

CorpDev.Org

Deal Intelligence Platform & Services for Global M&A / PE

Tuesday 7th July 2026
  • AI Diligence Platform
  • Expert Deal Services
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
  • About CorpDev.Org
  • Editorial Standards
CorpDev.Org

CorpDev.Org

Deal Intelligence Platform & Services for Global M&A / PE

  • AI Diligence Platform
  • Expert Deal Services
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
  • About CorpDev.Org
  • Editorial Standards

Author: Vyas Tungaturti

Vyas Tungaturti is a seasoned M&A operator and advisor specializing in large-scale mergers, acquisitions, and private equity due diligence. His experience spans integration and divestiture office leadership, complex cross-border transactions, and the application of AI and machine learning to deal execution. Founder of CorpDev.Org and builder of Kai, an AI due-diligence platform for deal teams, Vyas writes on deal intelligence, value creation, and how AI is reshaping M&A and PE workflows.
Novo’s $2.1B Vivtex Deal Boosts Obesity Drug Pipeline

Novo’s $2.1B Vivtex Deal Boosts Obesity Drug Pipeline

  • February 25, 2026
  • 0 Comments
  • By Vyas Tungaturti
TL;DR Novo Nordisk entered a partnership with Vivtex Corp. valued at up to $2.1 billion to develop oral medicines for obesity and diabetes. The deal leverages Vivtex's proprietary drug delivery...
Posted in Healthcare and Life Sciences
PE Still Vital to CalPERS’ Strategy Under TPA: CEO

PE Still Vital to CalPERS’ Strategy Under TPA: CEO

  • February 25, 2026
  • 0 Comments
  • By Vyas Tungaturti
TL;DR CalPERS, managing over $500 billion, maintains private equity as a core investment, targeting 13-15% allocation even after transitioning to a Third-Party Administrator (TPA) model in 2025. CEO...
Posted in Big Deal, Private Equity
GSK Secures Potential ‘Multi-Blockbuster’ Drug in $950 Million 35Pharma Acquisition

GSK Secures Potential ‘Multi-Blockbuster’ Drug in $950 Million 35Pharma Acquisition

  • February 25, 2026
  • 0 Comments
  • By Vyas Tungaturti
TL;DR GlaxoSmithKline (GSK) acquired Montreal-based 35Pharma Inc. for $950 million in cash, securing HS235, an investigational activin signaling inhibitor. This drug targets pulmonary hypertension,...
Posted in Healthcare and Life Sciences
Ardian to Reject Software Deals Over AI Risks in Private Equity Portfolio Strategy

Ardian to Reject Software Deals Over AI Risks in Private Equity Portfolio Strategy

  • February 25, 2026
  • 0 Comments
  • By Vyas Tungaturti
TL;DR Paris-based private equity firm Ardian, managing over €150 billion, is now rejecting certain software investments due to escalating AI-related risks. The firm cites volatile revenue...
Posted in Private Equity
EQT Withdraws Takeover Bid for Oxford Biomedica, Signaling Caution in Biotech M&A

EQT Withdraws Takeover Bid for Oxford Biomedica, Signaling Caution in Biotech M&A

  • February 25, 2026
  • 0 Comments
  • By Vyas Tungaturti
TL;DR Swedish private equity firm EQT has withdrawn its takeover bid for UK-based contract development and manufacturing organization (CDMO) Oxford Biomedica. The collapse is attributed to volatile...
Posted in Deal Drama, Private Equity
Unity Software Reviews Strategic Options for China Operations Amid Geopolitical Pressures

Unity Software Reviews Strategic Options for China Operations Amid Geopolitical Pressures

  • February 25, 2026
  • 0 Comments
  • By Vyas Tungaturti
TL;DR Unity Software is evaluating strategic options, including divestiture or restructuring, for its China operations, a move reported on February 24, 2026. This decision is driven by escalating...
Posted in Deal Drama, International, Technology, Media and Telecom
Japan’s Taiyo Holdings Nears Deal to Go Private Via KKR Buyout

Japan’s Taiyo Holdings Nears Deal to Go Private Via KKR Buyout

  • February 25, 2026
  • 0 Comments
  • By Vyas Tungaturti
KKR & Co. Inc. is in final talks to acquire Taiyo Holdings, positioning the Japanese firm for a privatization through a management buyout backed by the private equity giant. The tender offer price...
Posted in International, Private Equity
Kraft Heinz’s New CEO Blames Private Equity Cost Cuts for Lingering Challenges

Kraft Heinz’s New CEO Blames Private Equity Cost Cuts for Lingering Challenges

  • February 25, 2026
  • 0 Comments
  • By Vyas Tungaturti
TL;DR Kraft Heinz's incoming CEO has criticized the company's private equity-influenced past, specifically the deep cost reductions implemented by 3G Capital following the 2015 merger. These cuts,...
Posted in Big Deal, Deal Drama, Private Equity
ByteDance Valued at $550 Billion in Proposed Share Sale by General Atlantic, Sources Say

ByteDance Valued at $550 Billion in Proposed Share Sale by General Atlantic, Sources Say

  • February 25, 2026
  • 0 Comments
  • By Vyas Tungaturti
TL;DR General Atlantic is reportedly proposing to sell a stake in ByteDance, implying a $550 billion valuation for the TikTok parent, a significant increase from its $315 billion tender valuation in...
Posted in Big Deal, Private Equity
Private Equity Tries to Breathe New Life into US Hospice Chain

Private Equity Tries to Breathe New Life into US Hospice Chain

  • February 25, 2026
  • 0 Comments
  • By Vyas Tungaturti
TL;DR A private equity firm has agreed to acquire U.S. home health and hospice provider Enhabit Inc. (NYSE: EHAB) in a $1.1 billion take-private transaction. Spun off from Encompass Health in 2022,...
Posted in Private Equity

Posts navigation

Older posts
Newer posts

CorpDev.Org

24×7 real time deals updates for everyone associated with deals.  Bookmark the page!

Daily M&A/PE News In 5 Min

Recent Posts

  • Blackstone Abandons €2.5 Billion Pursuit of Ströer as Valuation Gaps Persist
  • Brookfield Bets on Global Air Cargo With $1.2 Billion WFC Acquisition
  • Blackstone and Google Launch $25 Billion AI Infrastructure Venture to Meet Exploding Data Center Demand
  • Paramount Readies $49 Billion Debt Sale as Warner Bros. Merger Enters Final Sprint
  • NextEra Energy’s $400 Billion Play for Dominion: Consolidation in the Age of AI

Categories

  • AI Diligence Platform
  • Expert Deal Services
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
  • About CorpDev.Org
  • Editorial Standards

Daily M&A/PE News In 5 Min

Deals by month

  • May 2026 (47)
  • April 2026 (27)
  • March 2026 (63)
  • February 2026 (68)
  • January 2026 (138)
  • December 2025 (139)
  • August 2025 (14)
  • July 2025 (78)
  • June 2025 (161)
  • May 2025 (163)
  • April 2025 (86)
  • January 2025 (53)
  • November 2024 (62)
  • October 2024 (102)
  • September 2024 (97)
  • August 2024 (165)
  • July 2024 (20)
  • March 2023 (7)
  • November 2022 (41)
  • October 2022 (89)
  • September 2022 (190)
  • August 2022 (80)
  • July 2022 (2)
  • June 2022 (79)
  • May 2022 (1)

Copyrights belong to 'Sources' referred to in each article, unless the articles are originally published by CorpDev.org in which case the copyright belongs to CorpDev.org